Food and Drug Administration, HHS.
Final rule; correction.
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of September 27, 2001 (66 FR 49276). The document issued a final rule establishing that cough-cold combination drug products containing any oral bronchodilator active ingredient in combination with any analgesic(s) or analgesic-antipyretic(s), anticholinergic, antihistamine, oral antitussive, or stimulant active ingredient are not generally recognized as safe and effective and are misbranded for over-the-counter (OTC) use. The document published with two inadvertent errors. This document corrects those errors.
This rule is effective October 19, 2001.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy, Planning, and Legislation (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.End Further Info End Preamble Start Supplemental Information
In FR Doc. 01-24127, appearing on page 49276 in the Federal Register of Thursday, September 27, 2001, the following corrections are made:
1. On page 49276, in the second column, in the third line, “Food and Drug Administration.” is corrected to read “Food and Drug Administration”.Start Signature
Dated: October 9, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy
[FR Doc. 01-26315 Filed 10-18-01; 8:45 am]
BILLING CODE 4160-01-S